Scraps From Possible Teva-Mylan Deal Tempt Drugmaker Amphastar

As Teva Pharmaceutical Industries Ltd. pushes to buy Mylan NV in a protracted takeover fight, drugmaker Amphastar Pharmaceuticals Inc. is interested in snapping up products that could get sold off for antitrust reasons.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.